Inventor · disambiguated record
Robert Walczak
Also filed as: WALCZAK JR ROBERT J · WALCZAK ROBERT · WALCZAK ROBERT JR
26 granted patents·14 pending applications·100 citations·filing 2005–2022
95Inventor score
Top patents by PatentIndex Score
40 records- 0194US11974997B2RORgamma modulators and uses thereofGENFIT·Filed 2021·Granted May 7, 2024·7 cites·14 claims
- 0293US12053456B2Pharmaceutical compositions for combination therapyGENFIT·Filed 2021·Granted Aug 6, 2024·3 cites·9 claims
- 0392US11590108B2Pharmaceutical compositions for combination therapyGENFIT·Filed 2018·Granted Feb 28, 2023·9 cites·8 claims
- 0491US11478440B2Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agentGENFIT·Filed 2018·Granted Oct 25, 2022·10 cites·3 claims
- 0586US11484517B2Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitorGENFIT·Filed 2018·Granted Nov 1, 2022·10 cites·2 claims
- 0686US10653678B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2018·Granted May 19, 2020·3 cites·6 claims
- 0786US8131799B2User-transparent system for uniquely identifying network-distributed devices without explicitly provided device or user identifying informationLANDSMAN RICK·Filed 2009·Granted Mar 6, 2012·23 cites·18 claims
- 0885US11052092B2N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseasesGENFIT·Filed 2018·Granted Jul 6, 2021·3 cites·16 claims
- 0985US11033534B2Pharmaceutical compositions for combination therapyGENFIT·Filed 2018·Granted Jun 15, 2021·3 cites·10 claims
- 1082US11400078B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2020·Granted Aug 2, 2022·1 cites·6 claims
- 1180US10905680B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2018·Granted Feb 2, 2021·1 cites·18 claims
- 1279US12208087B2Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammationGENFIT·Filed 2020·Granted Jan 28, 2025·1 cites·10 claims
- 1378US10130613B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2017·Granted Nov 20, 2018·1 cites·10 claims
- 1478US10130612B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2017·Granted Nov 20, 2018·1 cites·11 claims
- 1578US10117856B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2017·Granted Nov 6, 2018·1 cites·10 claims
- 1678US10117855B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2017·Granted Nov 6, 2018·1 cites·14 claims
- 1778US9902725B2Heterocyclic derivatives as RORgamma modulatorsGENFIT·Filed 2015·Granted Feb 27, 2018·4 cites·19 claims
- 1873US11103484B2Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2020·Granted Aug 31, 2021·0 cites·8 claims
- 1972US11191749B2Pharmaceutical compositions for combination therapyGENFIT·Filed 2018·Granted Dec 7, 2021·1 cites·8 claims
- 2065US2019000813A1Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2018·Application pending·0 cites
- 2165US2022323422A1Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2022·Application pending·0 cites
- 2263US10792277B2Methods of treatment of fibrosis and cancersGENFIT·Filed 2017·Granted Oct 6, 2020·0 cites·23 claims
- 2362USD733322SHexagonally-shaped solar heating swimming pool coverWALCZAK ROBERT·Filed 2014·Granted Jun 30, 2015·17 cites·1 claims
- 2461US2017290812A1Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2017·Application pending·0 cites
- 2558US11160801B2RORgamma modulators and uses thereofGENFIT·Filed 2018·Granted Nov 2, 2021·0 cites·20 claims
- 2658US2024216313A1Elafibranor derivatives agonists of ppar for use in the treatment of sepsisGENFIT·Filed 2022·Application pending·0 cites
- 2758US2023323308A1In vitro model of liver steatohepatitisGENFIT·Filed 2021·Application pending·0 cites
- 2855US2024000754A1Methods of treatment of liver failureGENFIT·Filed 2021·Application pending·0 cites
- 2952US2022056419A1In vitro model of liver steatosis and fibrosing non-alcoholic steatohepatitisGENFIT·Filed 2019·Application pending·0 cites
- 3051US2015352065A1Methods of treatment of fibrosis and cancersGENFIT·Filed 2014·Application pending·0 cites
- 3150US12391712B2Phosphate derivatives of RORgamma modulators and uses thereofGENFIT·Filed 2020·Granted Aug 19, 2025·0 cites·14 claims
- 3249US12458612B2Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonistsGENFIT·Filed 2020·Granted Nov 4, 2025·0 cites·15 claims
- 3349US2022401420A1Combination therapy having antioxydant propertiesGENFIT·Filed 2020·Application pending·0 cites
- 3447US2020054589A1Combination of a ppar agonist with a fxr agonistGENFIT·Filed 2018·Application pending·0 cites
- 3545US11077115B2Rorgamma modulators and uses thereofGENFIT·Filed 2018·Granted Aug 3, 2021·0 cites·18 claims
- 3644US2022193042A1Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stressGENFIT·Filed 2020·Application pending·0 cites
- 3742US10987351B2RORgamma modulators and uses thereofGENFIT·Filed 2018·Granted Apr 27, 2021·0 cites·13 claims
- 3842US2006100928A1System and method for providing content to a mobile communication deviceWALCZAK ROBERT JR·Filed 2005·Application pending·0 cites
- 3938US2017290813A1Methods of treatment for cholestatic and fibrotic diseasesGENFIT·Filed 2017·Application pending·0 cites
- 4036US2017290814A1Methods of treatment of cholestasis and fibrosisGENFIT·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →